Determination of antiviral action of long non-coding RNA loc107051710 during infectious bursal disease virus infection due to enhancement of interferon production

Virulence. 2020 Dec;11(1):68-79. doi: 10.1080/21505594.2019.1707957.

Abstract

The functions and profiles of lncRNAs during infectious bursal disease virus (IBDV) infection have not been determined, yet. The objectives of this study were to determine the antiviral action of loc107051710 lncRNA during IBDV infection by investigating the relationship between loc107051710 and IRF8, Type I IFN, STATs, and ISGs. DF-1 cells were either left untreated as non-infected controls (n = 1) or infected with IBDV (n = 3). RNA sequencing was applied for analysis of mRNAs and lncRNAs expression. Differentially expressed genes were verified by RT-qPCR. Then identification, of 230 significantly different expressed genes (182 mRNAs and 48 lncRNA) by pairwise comparison of the infected and control groups, was carried out. The functions of differentially expressed lncRNAs were investigated by selection of lncRNAs and mRNAs significantly enriched in the aforementioned biological processes and signaling pathways for construction of lncRNA-mRNA co-expression networks. The techniques of gene ontology and Kyoto Encyclopedia of Genes and Genomes pathways were applied. It was suggested that these differentially expressed genes were involved in the interaction between the host and IBDV. Loc107051710 was found to have potential antiviral effects. RT-qPCR and western blot were applied and revealed that loc107051710 was required for induction of IRF8, type I IFN, STAT, and ISG expression, and its knockdown promoted IBDV replication. By fluorescence in situ hybridization, it was found that loc107051710 was translocated from the nucleus to the cytoplasm after infection with IBDV. Overall, loc107051710 promoted the production of IFN-α and IFN-β by regulating IRF8, thereby promoting the antiviral activity of ISGs.

Keywords: IRF8; Infectious bursal disease virus; interferon-stimulated gene; lncRNA; loc107051710; type I interferon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / metabolism
  • Antiviral Agents / pharmacology*
  • Biological Phenomena
  • Birnaviridae Infections
  • Cell Line
  • Chickens
  • Fibroblasts
  • Gene Expression
  • In Situ Hybridization, Fluorescence
  • Infectious bursal disease virus / drug effects*
  • Infectious bursal disease virus / metabolism
  • Interferon-beta
  • Interferons / metabolism*
  • Poultry Diseases / virology
  • Protein Interaction Maps
  • RNA, Long Noncoding / genetics*
  • RNA, Long Noncoding / metabolism*
  • RNA, Long Noncoding / pharmacology
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Transcriptome
  • Virus Replication

Substances

  • Antiviral Agents
  • RNA, Long Noncoding
  • RNA, Messenger
  • Interferon-beta
  • Interferons

Grants and funding

This work is supported by the National Science and Technology Support Program in Rural Areas of the12th Five-Year Plan [Grant 2015BAD12B01].